In this episode of ISTAART Voices, Dr. Sietske Sikkes and Dr. Mark Dubbelman reveal the complex challenges of pooling data from multiple Alzheimer's disease clinical trials. Their research highlights significant barriers in accessing and analyzing historical trial data, demonstrating the critical need for more open and streamlined scientific collaboration. This discussion underscores the importance of making clinical trial data more accessible to advance personalized medicine and understanding of Alzheimer's disease treatment responsiveness.

Special thanks to ISTAART Ambassador Lucy Core for her contributions to the production of this episode of ISTAART Voices.

Links

• Show page: alz.org/ISTAARTpodcast 
• ISTAART: alz.org/ISTAART 
• Featured paper: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.12485
• Dr. Mark A. Dubbelman: https://connects.catalyst.harvard.edu/Profiles/display/Person/213733
• Dr. Sietske A. M. Sikkes: https://research.vu.nl/en/persons/sietske-sikkes
• Professional Interest Areas (PIAs): alz.org/ISTAARTPIAS 
• Podcast CMEs: alz.org/ISTAARTpodcastCME
• Alzheimer's Association International Conference® 2025 (AAIC®): alz.org/AAIC
• Alzheimer's Association Scientific Meetings: alz.org/scientificmeetings 
• Alzheimer's Association Journal Family: alz.org/journals 
• Social: #ISTAART @ISTAART 

The views and opinions expressed in this podcast are solely those of the guests and do not necessarily reflect those of the Alzheimer's Association. The Alzheimer's Association does not endorse any external product or service. This podcast is for informational purposes and is not intended to provide medical advice, please consult your physician.

Hosted on Acast. See acast.com/privacy for more information.